P197 Evaluating the safety and factors associated with treatment cessation in Takayasu arteritis
Sign Up to like & getrecommendations! Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead104.238
Abstract: Immunosuppression in Takayasu arteritis (TA) reduces the risk of arterial disease progression. However, long-term use of glucocorticoids (GC) and other agents carries risk, particularly as patients age. GC tapering practice can vary and there are… read more here.
Keywords: takayasu arteritis; cessation cases; treatment cessation; cessation ... See more keywords